Skip to main content
Back to News
RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr...
Funding
1 min read
US

RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr...

The AMW Read

Updates the player map for Vertical AI (Healthcare) with a new Series A entrant focused on agentic workflows for administrative oncology bottlenecks.
NoveltySignificance
Healthcare & Bio Β· Player MapAI Agents Β· Definition

RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-driven oncology operating system. Their BOSS platform uses AI agents to slash prior authorization times from 30 minutes to under 5, addressing a critical bottleneck where administrative delays increase patient mortality risk by 13%. This signifies a shift toward agentic AI that autonomously executes complex, high-stakes tasks by unifying data across disparate EMR and payer systems. πŸš€

#AI #HealthTech #Oncology #VCFunding

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1d agoPathos AI raises $237M to scale Foundry and advance four oncology assetsPathos
  2. 2d agoWarp Sciences, founded by former OpenAI science lead Kevin Weil, raises $215M to automate drug-chemistry labsWarp Sciences
  3. 3d agoWarp Sciences raises $215 million for robotic drug-discovery labsWarp Sciences
  4. 1mo agoLevel Five, a game developer, has issued a public apology after facing criticism for what it called...Level Five
  5. 9mo agoRISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr... Β· THIS ARTICLE

Related News

More news from Risa Labs Inc.

Stay updated with the latest news and announcements from Risa Labs Inc..

View all Risa Labs Inc. news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard